Physician profile
Robert C Parajon
NPI 1053382838
$2,995.18
in general payments reported to CMS, 2019-2025
18 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $247 · 2021: $448 · 2022: $179 · 2023: $479 · 2024: $577 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,439.30 | 2020-2025 | Variax, Dart-Fire, Allowrap |
| Sandoz INC. | $397.65 | 2019-2021 | |
| Treace Medical Concepts, INC. | $247.77 | 2022-2025 | |
| Organogenesis INC. | $181.51 | 2021-2025 | Affinity, Novachor, Apligraf |
| Paratek Pharmaceuticals, INC. | $160.82 | 2020-2022 | |
| Amgen INC. | $154.43 | 2020-2024 | Krystexxa |
| Smith+Nephew, INC. | $88.82 | 2019-2020 | |
| Medtronic, INC. | $79.90 | 2021 | |
| Tactile Systems Technology INC | $47.91 | 2023 | Entre Plus, Flexitouch Plus |
| Paragon 28, INC. | $35.22 | 2019-2021 | |
| Bioventus LLC | $34.85 | 2023 | Exogen Ultrasound Bone Healing System |
| Lilly USA, LLC | $30.51 | 2019 | |
| Adamas Pharmaceuticals, INC. | $21.91 | 2021 | |
| Horizon Therapeutics Plc | $18.02 | 2019 | |
| Averitas Pharma INC. | $17.35 | 2024 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $14.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2023 | Seglentis |
| Regeneron Healthcare Solutions, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parajon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.